Personalised medicine
Paving the way for personalised medicine 2019
Important Dates
About Personalised medicine
PM generates numerous questions and concerns either in terms of ethics, human rights, financing and other perspectives, addressing: What progress has been made so far bringing PM technologies to the market? How to overcome clinical trials challenges with PM? Is there any evidence of more efficiency in health care by introducing PM approaches? Are we morally obligated to implement PM innovations? What are the regulatory barriers to PM developments? What is the influence of patent law on PM innovations? PM and processing genomic data, what are the GDPR risks? What are the solutions to identified concerns?
Topics
Human rights law, Patents, Regenerative medicine, Health economics, Epigenetics, Health care, Bioethics, Health lawCall for Papers
Call for Abstracts
The conference has a multidisciplinary approach inviting academics, professionals, (PhD) students and other interested persons to participate and submit an abstract for presentation, addressing the above mentioned or related issues.
Those who wish to present should send an abstract (max. 300 words) of their proposed presentation to the Chair of the Scientific Committee (denexter@law.eur.nl) (deadline: 1 September 2019). A short bibliography may be attached on additional pages (optional). The abstracts will be subjected to a peer review process by the Conference’s Scientific Committee. Submissions will be reviewed on a rolling basis (each submission will be reviewed within a short period from its reception). Those who are selected are expected to present their paper at the Conference to take place on 18 November 2019. They will be given 15 minutes to present, plus 5 minutes for discussion.
Sign up and follow your favorite conferences.
